Finkelstein Thompson LLP Announces Investigation of Continucare Corporation

WASHINGTON--(BUSINESS WIRE)--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Continucare Corporation (“Continucare” or the “Company”) (NYSE: CNU) concerning the proposed acquisition of the Company by Metropolitan Health Networks, Inc. (“Metropolitan”) (NYSE AMEX: MDF). Under the terms of the transaction, Continucare’s shareholders would receive $6.25 per share in cash. Shareholders would also receive 0.0414 of a share of Metropolitan common stock for each share they own, presently valued at approximately $0.19.